The global in-vitro diagnostic market is growing rapidly and is expected to increase from 56.68 billion USD in 2015 to 68.81 billion USD by 2019 at a CAGR of 5.0%. According to QYR, it is estimated to reach 306.62 billion USD by 2025. As the average income increases and the living standard improves, people also demand higher standards for health and medical quality. Under these favorable conditions, the IVD Industry is facing a golden opportunity in the history of medical development.
The IVD industry is becoming more recognized as modern medicine continued to develop. The development of IVD technologies also facilitates the development of Laboratory Medicine, Preclinical Medicine, and other related areas. To date, IVD results have more than 70% influence on clinical decision-making, which is the scientific basis for clinicians to decide follow-up treatment plans. IVD has applications in all aspects of disease prevention, diagnosis testing, and post-treatment evaluation. It is a crucial part of the medical and health industry.
Coenzyme is the core biological raw material of IVD reagents. Abiochem has developed a variety of important IVD coenzyme products based on our biosynthetic technology.